Cancer Immunology

A cancer vaccine is an immunization that either treats existing tumor or averts improvement of a malignancy. Antibodies that regard existing malignancy are known as restorative tumor vaccines. One way to deal with disease immunization is to separate proteins from growth cells and vaccinate patients against those proteins as antigens, in the expectation of empowering the immune system to execute the cancer cells. Another approach is to produce a resistant reaction in situ in the patient utilizing oncolytic infections.

  • Tumor vaccines
  • Oncolytic infections
  • Resistant reactions in situ
  • Proteins as antigens

Related Conference of Cancer Immunology

April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2025

38th Conference on Preventive Oncology and Diagnostic Cancer

Rome, Italy
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 09-10, 2025

3rd International Conference on Cancer Biology and Therapeutics

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
June 19-20, 2025

7th International Conference on Women Oncology

London, UK
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

4th Experts Meeting on Cancer Medicine, Radiology & Treatment

Paris, France
November 24-25, 2025

47th Euro-Global Summit on Cancer Therapy & Radiation Oncology

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Cancer Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in